{
    "organizations": [],
    "uuid": "b170e566591d979b91f4e9c1a03a6256ea5205a0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bioinvent-appoints-martin-welschof/brief-bioinvent-appoints-martin-welschof-new-ceo-idUSASO00037Q",
    "ord_in_thread": 0,
    "title": "BRIEF-Bioinvent appoints Martin Welschof new CEO",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 12 (Reuters) - BioInvent International AB:\n* BIOINVENT RECRUITS MARTIN WELSCHOF AS NEW CEO * BIOINVENT SAYS HE WILL TAKE OFFICE WITHIN FIVE MONTHS TO ALLOW FOR CONCLUSION OF ONGOING BUSINESS DISCUSSIONS AT OPSONA THERAPEUTICS Source text for Eikon: Further company coverage: (Reporting By Anna Ringstrom)\n ",
    "published": "2018-04-12T14:34:00.000+03:00",
    "crawled": "2018-04-13T17:42:07.008+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "bioinvent",
        "international",
        "ab",
        "bioinvent",
        "recruit",
        "martin",
        "welschof",
        "new",
        "ceo",
        "bioinvent",
        "say",
        "take",
        "office",
        "within",
        "five",
        "month",
        "allow",
        "conclusion",
        "ongoing",
        "business",
        "discussion",
        "opsona",
        "therapeutic",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "anna",
        "ringstrom"
    ]
}